NIKKEI 225
38,703.51 +213.34 (+0.55%) HANG SENG
18,476.80 +51.84 (+0.28%) CRUDE OIL
75.59 +1.52 (+2.05%) GOLD FUTURES
2,393.80 +18.30 (+0.77%) DOW
38,893.10 +85.77 (+0.22%) Bitcoin GBP
55,393.39 -67.81 (-0.12%)
JNJ Jul 2024 120.000 call
- Insider Monkey
Is Johnson & Johnson (NYSE:JNJ) the Best Mega-Cap Dividend Aristocrat Stock?
We recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since Johnson & Johnson (NYSE:JNJ) ranks higher on our list, we have analyzed the stock in detail. The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm. Between these two, dividend growth is currently […]
- Insider Monkey
Is Johnson & Johnson A Good Quality Stock to Buy Now?
We recently compiled the list of the 13 Best Quality Stocks to Buy Now according to the hedge funds using the latest sentiment data. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other quality stocks. Investing in 2024 is significantly different from investing in […]
- Zacks
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
The late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with relapsed/refractory multiple myeloma who have received at least two lines of prior therapy.
